Chemical industry – Page 31
-
BusinessChinese plant closures disrupt supply chains
Environmental clampdown knocks out major suppliers of some ingredients
-
BusinessBristol-Myers Squibb to buy Celgene for $74 billion
Deal boosts BMS’s cancer and immunology pipeline with 5 drugs in late stage clinical trials
-
CareersRethinking industrial placements
How SMEs are bridging the gap between undergraduates and industry
-
ArticleStrength through diversity
Why people should be at the heart of a forward-thinking contract research organisation
-
BusinessHow many papers do you read a week?
Everyone needs a strategy to keep up with the literature
-
BusinessGSK and Pfizer joint venture creates new consumer healthcare giant
Enlarged GSK consumer health will have largest market share of any firm and be a leader in key countries
-
-
OpinionHow science shapes our psychology
We learn to embrace the unexpected, follow evidence over opinion and accept that most experiments fail
-
BusinessChemicals industry roundup 2018
Industry growth remains strong despite tariff disputes, political uncertainty and supply chain challenges
-
BusinessPharmaceuticals roundup 2018
Merger deals, product approvals and infrastructure changes have been overshadowed by political uncertainty, in Europe and around the world
-
BusinessBayer to cut 12000 jobs
As it integrates Monsanto businesses, Bayer will eliminate around 10% of its global workforce
-
BusinessSartan drug contamination brings cancer uncertainty
Levels of nitrosamines and other carcinogens in affected tablets of valsartan and related drugs similar to smoking 20 cigarettes a day
-
BusinessSensing the sweet spot
Ziylo’s selective glucose-binding molecule could open doors to smart insulin for diabetes
-
BusinessArrests in China follow massive leak into the Taiwan Strait
Seven charged with criminal negligence after release of 70 tonnes of aromatic hydrocarbons sickened over 50 people
-
OpinionPushing the limits of patent protection
Some methods of extending exclusivity rights raise legal and ethical questions
-
BusinessBreaking the silence of RNA interference drugs
A wave of treatments is set to follow the first approval of an RNAi therapy
-
WhitepaperTesting for mosquito repellent residue
High-quality reference materials advance analyses, save time, and reduce costs
-
ReviewBitter Pills: The Global War on Counterfeit Drugs
Muhammad Zaman’s book gives an account of the challenges facing drug regulators worldwide
-
-
